| |
|
|
|
|
|
|
|||
|
Blood, 15 January 2007, Vol. 109, No. 2, pp. 449-456. Prepublished online as a Blood First Edition Paper on September 14, 2006; DOI 10.1182/blood-2006-04-018101.
Submitted August 10, 2005
Dept of Immunology, Toho University School of Medicine, Tokyo, Japan * Corresponding author; email: tkaki{at}med.toho-u.ac.jp.
Secondary lymphoid organs (SLOs) provide a niche for the initiation and regulation of T cell responses, but the mechanisms have been poorly understood. We investigated the influence of chemokines CCL19 and CCL21 constitutively expressed in SLOs on activation-induced cell death (AICD) of CD4+ T cells. When paucity of lymph node T cells (plt) mutant mice lacking expression of CCL19/CCL21 were primed with OVA/CFA, both expansion of OVA-responding CD4+ T cells in the draining lymph nodes and an in vitro recall-response were prolonged as compared with responses in wild type (WT) mice. The apoptotic cell frequency among OVA-responding CD4+ T cells was similarly low in plt/plt and WT mice during clonal expansion phase. However, during the clonal contraction phase, the frequency never increased in plt/plt mice, whereas in WT mice it continuously increased to a peak 18 days after immunization. The presence of CCL19/CCL21 during the in vitro stimulation of CD4+ T cells with anti-CD3+anti-CD28 significantly enhanced in vitro AICD induction of the restimulated T cells, partially through enhancing Fas-ligand expression. Our results suggest that CCL19/CCL21 produced by stromal cells and antigen-presenting cells regulate CD4+ T cell immune responses in SLOs by promoting AICD.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||